LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that it will introduce a Waive Generic Copayment program in 2007 to its fully insured Commercial members on tiered copay prescription drug plans.
Under the program, members who elect to switch to generic alternatives for certain classes of medications where they are available will have the first copayment for their prescription waived. The targeted classes of medications include proton pump inhibitors (heartburn medications), Cox 2 inhibitors (pain medications), hypertension, cholesterol, depression and diabetes oral medications.
“Humana’s goal is to raise awareness of the availability and value of generic medications which may help consumers save money while providing the same medical result,” said William Fleming, PharmD, vice president of pharmacy and clinical integration. “Numerous brand medications have therapeutically equivalent generics available and we encourage our members to talk with their physicians about whether a generic alternative is right for them.”
Providing information on choices and options is core to Humana’s consumer-oriented strategy and the Waive Generic Copayment campaign is the most recent addition to the company’s robust menu of money-saving and quality-enhancing guidance tools. The campaign will entail providing information through written correspondence to members. Humana health plan members can use Humana’s award winning online Pharmacy tools found on www.humana.com to determine their potential out-of-pocket savings associated with using generic alternatives.
Humana Inc., headquartered in Louisville, Kentucky, is one of the nation’s largest publicly traded health benefits companies, with more than 11 million medical members. Humana offers a diversified portfolio of health insurance products and related services – through traditional and consumer-choice plans – to employer groups, government-sponsored plans, and individuals.
Over its 45-year history, Humana has consistently seized opportunities to meet changing customer needs. Today, the company is a leader in consumer engagement, providing guidance that leads to lower costs and a better health plan experience throughout its diversified customer portfolio.
More information regarding Humana is available to investors via the Investor Relations page of the company’s web site at http://www.humana.com, including copies of: